These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25611048)

  • 1. Multiple relapses in high-grade osteosarcoma: when to stop aggressive therapy?
    Tamamyan G; Dominkus M; Lang S; Diakos C; Mittheisz E; Horcher E; Holter W; Zoubek A; Bielack S; Kager L
    Pediatr Blood Cancer; 2015 Mar; 62(3):529-30. PubMed ID: 25611048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognostic factors for the local recurrence of osteosarcoma in extremities treated with combined therapy].
    Zhang Q; Niu XH; Cai YB; Hao L; Ding Y
    Zhonghua Wai Ke Za Zhi; 2007 Aug; 45(16):1114-7. PubMed ID: 18005614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastatic osteosarcoma at diagnosis: prognostic factors and long-term outcome--the French pediatric experience.
    Mialou V; Philip T; Kalifa C; Perol D; Gentet JC; Marec-Berard P; Pacquement H; Chastagner P; Defaschelles AS; Hartmann O
    Cancer; 2005 Sep; 104(5):1100-9. PubMed ID: 16015627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synchronous and metachronous skeletal osteosarcomas: the Norwegian Radium Hospital experience.
    Brandal P; Bjerkehagen B; Bruland OS; Skjeldal S; Bogsrud TV; Hall KS
    Acta Oncol; 2009; 48(8):1165-72. PubMed ID: 19863225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of management issues in relapsed osteosarcoma.
    Vijayamurugan N; Bakhshi S
    Expert Rev Anticancer Ther; 2014 Feb; 14(2):151-61. PubMed ID: 24308680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neoadjuvant therapy for localized osteosarcoma of extremities. Results from the Cooperative osteosarcoma study group COSS of 925 patients].
    Bielack S; Kempf-Bielack B; Schwenzer D; Birkfellner T; Delling G; Ewerbeck V; Exner GU; Fuchs N; Göbel U; Graf N; Heise U; Helmke K; von Hochstetter AR; Jürgens H; Maas R; Münchow N; Salzer-Kuntschik M; Treuner J; Veltmann U; Werner M; Winkelmann W; Zoubek A; Kotz R
    Klin Padiatr; 1999; 211(4):260-70. PubMed ID: 10472560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS).
    Kempf-Bielack B; Bielack SS; Jürgens H; Branscheid D; Berdel WE; Exner GU; Göbel U; Helmke K; Jundt G; Kabisch H; Kevric M; Klingebiel T; Kotz R; Maas R; Schwarz R; Semik M; Treuner J; Zoubek A; Winkler K
    J Clin Oncol; 2005 Jan; 23(3):559-68. PubMed ID: 15659502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of osteosarcoma at first recurrence after contemporary therapy: the Memorial Sloan-Kettering Cancer Center experience.
    Chou AJ; Merola PR; Wexler LH; Gorlick RG; Vyas YM; Healey JH; LaQuaglia MP; Huvos AG; Meyers PA
    Cancer; 2005 Nov; 104(10):2214-21. PubMed ID: 16206297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of bone allografts for limb salvage in high-grade extremity osteosarcoma.
    Gebhardt MC; Flugstad DI; Springfield DS; Mankin HJ
    Clin Orthop Relat Res; 1991 Sep; (270):181-96. PubMed ID: 1884538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [High grade osteosarcoma of the lower limb. Complications and results of the treatment of 20 patients].
    Babin SR; Simon P; Babin-Boilletot A; Bellocq JP; Marcellin L; Dosch JC
    Rev Chir Orthop Reparatrice Appar Mot; 1996; 82(1):14-21. PubMed ID: 8762984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome after polychemotherapy and intensive local radiation therapy of high-grade osteosarcoma.
    Hundsdoerfer P; Albrecht M; Rühl U; Fengler R; Kulozik AE; Henze G
    Eur J Cancer; 2009 Sep; 45(14):2447-51. PubMed ID: 19596190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteosarcoma: the COSS experience.
    Bielack S; Jürgens H; Jundt G; Kevric M; Kühne T; Reichardt P; Zoubek A; Werner M; Winkelmann W; Kotz R
    Cancer Treat Res; 2009; 152():289-308. PubMed ID: 20213397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.
    Kager L; Zoubek A; Pötschger U; Kastner U; Flege S; Kempf-Bielack B; Branscheid D; Kotz R; Salzer-Kuntschik M; Winkelmann W; Jundt G; Kabisch H; Reichardt P; Jürgens H; Gadner H; Bielack SS;
    J Clin Oncol; 2003 May; 21(10):2011-8. PubMed ID: 12743156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognosis of patients with primary osteosarcoma who have undergone unplanned therapy.
    Wang TI; Wu PK; Chen CF; Chen WM; Yen CC; Hung GY; Liu CL; Chen TH
    Jpn J Clin Oncol; 2011 Nov; 41(11):1244-50. PubMed ID: 21994209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose chemotherapy (HDC) and autologous hematopoietic stem cell transplantation (ASCT) as salvage therapy for relapsed osteosarcoma.
    Sauerbrey A; Bielack S; Kempf-Bielack B; Zoubek A; Paulussen M; Zintl F
    Bone Marrow Transplant; 2001 May; 27(9):933-7. PubMed ID: 11436103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment algorithm for locally recurrent osteosarcoma based on local disease-free interval and the presence of lung metastasis.
    Nathan SS; Gorlick R; Bukata S; Chou A; Morris CD; Boland PJ; Huvos AG; Meyers PA; Healey JH
    Cancer; 2006 Oct; 107(7):1607-16. PubMed ID: 16933325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment and outcome of recurrent osteosarcoma: experience at Rizzoli in 235 patients initially treated with neoadjuvant chemotherapy.
    Bacci G; Briccoli A; Longhi A; Ferrari S; Mercuri M; Faggioli F; Versari M; Picci P
    Acta Oncol; 2005; 44(7):748-55. PubMed ID: 16227167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is the best clinical approach to recurrent/refractory osteosarcoma?
    Meazza C; Bastoni S; Scanagatta P
    Expert Rev Anticancer Ther; 2020 May; 20(5):415-428. PubMed ID: 32379504
    [No Abstract]   [Full Text] [Related]  

  • 19. Prognostic relevance of increased angiogenesis in osteosarcoma.
    Kreuter M; Bieker R; Bielack SS; Auras T; Buerger H; Gosheger G; Jurgens H; Berdel WE; Mesters RM
    Clin Cancer Res; 2004 Dec; 10(24):8531-7. PubMed ID: 15623635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a Model System to Evaluate Local Recurrence in Osteosarcoma and Assessment of the Effects of Bone Morphogenetic Protein-2.
    Geller DS; Singh MY; Zhang W; Gill J; Roth ME; Kim MY; Xie X; Singh CK; Dorfman HD; Villanueva-Siles E; Park A; Piperdi S; Gorlick R
    Clin Cancer Res; 2015 Jul; 21(13):3003-12. PubMed ID: 25472999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.